May 16, 2023 / 04:30PM GMT
Daniel Stauder - JMP Securities LLC - Analyst
Welcome to day two of the JMP Life Sciences Conference. I'm pleased to introduce members of Neuronetics management team. We have CEO, Keith Sullivan; CFO, Steve Furlong. Before we get into it, just as a reminder, Neuronetics is a leader in the TMS space, treating a range of neurological disorders, primarily major depressive disorder.
Questions and Answers:
Daniel Stauder - JMP Securities LLC - AnalystSo just with that, let's get going. Keith, you've been at the helm for almost three years now. We would love to hear your high-level perspective on where the TMS market stands right now, what has changed in the industry since you've joined, and where Neuronetics stands within that today.
Keith Sullivan - Neuronetics, Inc. - President & CEO
Very good. Well, thanks for having us.
Daniel Stauder - JMP Securities LLC - Analyst
Of course. Thank you for coming.
Keith Sullivan - Neuronetics, Inc. -